Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA Approves Pfizer’s Hympavzi for Hemophilia A, B
The US Food and Drug Administration (FDA) has approved Hympavzi (marstacimab, Pfizer) as routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients 12 years or older who have hemophilia A without factor VIII inhibitors or hemophilia…
English